Caris Life Sciences announces collaborative new research on TET2 [Yahoo! Finance]
Caris Life Sciences, Inc. (CAI)
Last caris life sciences, inc. earnings: 10/29 04:00 pm
Check Earnings Report
US:NYSE Investor Relations:
investor.capps.com/investor-relations
Company Research
Source: Yahoo! Finance
for improved response to immune checkpoint inhibitor, or ICI, therapy in patients with solid tumors. The study titled, ‘TET2-mutant clonal hematopoiesis enhances macrophage antigen presentation and improves immune checkpoint therapy in solid tumors,' was led by Padmanee Sharma, at the James P. Allison Institute at The University of Texas MD Anderson Cancer Center and published in Cancer Cell. The study's purpose was to investigate how immune cells carrying CH-derived TET2 mutations influence solid tumor immunology and respond to ICI therapy. Dr. Sharma and Shelley Herbrich, Ph.D., postdoctoral fellow in Dr. Sharma's lab, explored the underlying mechanisms using TET2-mutant laboratory models, which revealed how these mutations shape immune dynamics within the tumor microenvironment. To validate the clinical relevance of these findings, the study leveraged Caris Life Sciences' extensive clinico-genomic database, analyzing outcomes in a real-world cohort of nearly 36,000 patients with no
Show less
Read more
Impact Snapshot
Event Time:
CAI
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CAI alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CAI alerts
High impacting Caris Life Sciences, Inc. news events
Weekly update
A roundup of the hottest topics
CAI
News
- Caris Life Sciences to Showcase 19 Studies at the 2025 San Antonio Breast Cancer Symposium [Yahoo! Finance]Yahoo! Finance
- Caris Life Sciences to Showcase 19 Studies at the 2025 San Antonio Breast Cancer SymposiumPR Newswire
- The Caris Precision Oncology Alliance Welcomes UAMS Winthrop P. Rockefeller Cancer InstitutePR Newswire
- Caris Precision Oncology Alliance Fellows Forum Welcomes 2025/2026 Class [Yahoo! Finance]Yahoo! Finance
- Caris Precision Oncology Alliance Fellows Forum Welcomes 2025/2026 ClassPR Newswire
CAI
Earnings
- 11/5/25 - Beat
CAI
Sec Filings
- 11/10/25 - Form 4
- 11/10/25 - Form 4
- 11/5/25 - Form 10-Q
- CAI's page on the SEC website